Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Lung Strategy in Critically Ill Morbid Obese Patients Lung Imaging and Heart-lung Interaction

NCT02503241 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT02503241
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02503241 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Lung Strategy in Critically Ill Morbid Obese Patients Lung Imaging and Heart-lung Interaction
Lead sponsor
Massachusetts General Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
April 30, 2016
Completion date
June 30, 2022
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obesity, pulmonary atelectasis, respiratory insufficiency, respiratory mechanics, right-sided heart failure